Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.88 - $3.56 $88,380 - $167,359
-47,011 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$1.47 - $3.29 $7,067 - $15,818
4,808 Added 11.39%
47,011 $105,000
Q1 2020

May 13, 2020

BUY
$1.59 - $3.35 $766 - $1,614
482 Added 1.16%
42,203 $80,000
Q2 2019

Aug 14, 2019

BUY
$5.15 - $7.92 $214,863 - $330,430
41,721 New
41,721 $330,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $257M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.